Search

Author/Creator Maishman, T.

2. ACCEPT: A PHASE IB/II COMBINATION OF ACALABRUTINIB WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISOLONE (R‐CHOP) FOR PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (12th June 2019)

Authors:
Cummin, T.E.; Caddy, J.; Mercer, K.; Maishman, T.; Schuh, A.; Lopez Pascua, L.; Collins, G.; McMillan, A.; Ardeshna, K.; Galanopoulous, A.; Burton, C.; Barrans, S.; Griffiths, G.; Johnson, P.; Davies, A.J.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B. (June 2017)

Authors:
Davies, A.J.; Barrans, S.; Maishman, T.; Cummin, T.E.; Bentley, M.; Mamot, C.; Novak, U.; Caddy, J.; Hamid, D.; Kazmi‐Stokes, S.H.; Mcmillan, A.; Fields, P.A.; Pocock, C.; Kruger, A.; Collins, G.; Sha, C.; Clipson, A.; Wang, M.; Tooze, R.M.; Care, M.A.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Family history and outcome of young patients with breast cancer in the UK (POSH study). Issue 8 (20th May 2015)

Authors:
Eccles, B. K.; Copson, E. R.; Cutress, R. I.; Maishman, T.; Altman, D. G.; Simmonds, P.; Gerty, S. M.; Durcan, L.; Stanton, L.; Eccles, D. M.; the POSH Study Steering Group; Eccles, D.; Simmonds, P.; Altman, D. G.; Pharoah, P.; Warren, R.; Gilbert, F.; Jones, L.; Eeles, R.; Evans, D. G. R.
Journal:
British journal of surgery
Issue:
Volume 102:Issue 8(2015:Aug.)
Page Start:
924
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. PROGNOSTIC SIGNIFICANCE AND CORRELATION TO GENE EXPRESSION PROFILE OF EZH2 MUTATIONS IN DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL) IN 2 LARGE PROSPECTIVE STUDIES. (June 2017)

Authors:
Cummin, T.E.; Araf, S.; Du, M.; Barrans, S.; Bentley, M.A.; Clipson, A.; Wang, M.; Ahmed, S.; Rahim, T.; Shah, C.; Hamid, D.; Dhondt, J.; Maishman, T.; Vaughan‐Spickers, N.; Pocock, C.; Forbes, A.; O'Callaghan, A.; Westhead, D.; Griffiths, G.O.; Fitzgibbon, J.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review. (December 2018)

Authors:
Copson, E.; Shaaban, A.M.; Maishman, T.; Moseley, P.M.; McKenzie, H.; Bradbury, J.; Borley, A.; Brzezinska, M.; Chan, S.Y.T.; Ching, J.; Cutress, R.I.; Danial, I.; Dall, B.; Kerin, M.; Lowery, A.J.; Macpherson, I.R.; Romics, L.; Sawyer, E.; Sharmat, N.; Sircar, T.
Journal:
Breast
Issue:
Volume 42(2018)
Page Start:
133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial. (August 2019)

Authors:
Moore, M.; Trill, J.; Simpson, C.; Webley, F.; Radford, M.; Stanton, L.; Maishman, T.; Galanopoulou, A.; Flower, A.; Eyles, C.; Willcox, M.; Hay, A.D.; van der Werf, E.; Gibbons, S.; Lewith, G.; Little, P.; Griffiths, G.
Journal:
Clinical microbiology and infection
Issue:
Volume 25:Number 8(2019)
Page Start:
973
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗